Compare
Precision Optics Corporation, Inc. vs electroCore, Inc. vs QT Imaging Holdings, Inc. vs Outset Medical, Inc.
| Latest fiscal year | Precision Optics Corporation, Inc. POCI | electroCore, Inc. ECOR | QT Imaging Holdings, Inc. QTI | Outset Medical, Inc. OM |
|---|---|---|---|---|
| Year ended | 2026-06-30 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $31.53M | $32.03M | $18.93M | $119.48M |
| Revenue growth (YoY) | +65.2% | +27.2% | +287.9% | +5.1% |
| Gross margin | 17.2% | 86.8% | 45.4% | 39.1% |
| Operating margin | -11.1% | -41.1% | -23.4% | -55.8% |
| Net margin | -11.5% | -43.6% | -111.4% | -68.3% |
| Net income | -$3.63M | -$13.97M | -$21.08M | -$81.65M |
| EPS (Diluted) | -$0.43 | -$1.65 | -$2.01 | -$5.37 |
| Operating cash flow | -$1.55M | -$8.19M | -$8.96M | -$46.33M |
| Free cash flow | -$1.98M | -$8.25M | -$9.08M | -$47.12M |
| Cash & equivalents | $9.84M | $7.04M | $10.41M | $35.01M |
| Total assets | $32.34M | $18.67M | $23.02M | $264.50M |
| Total liabilities | $11.99M | $20.38M | $16.58M | $137.54M |
| Shareholders' equity | $20.35M | -$1.71M | $6.45M | $126.95M |
| Return on year-end equity | -17.8% | n/a | -327.1% | -64.3% |
| Shares outstanding | 10.97M | 8.00M | 11.90M | 18.17M |
Revenue, most recent five fiscal years
| Fiscal year | Precision Optics Corporation, Inc. | electroCore, Inc. | QT Imaging Holdings, Inc. | Outset Medical, Inc. |
|---|---|---|---|---|
| Latest | $31.53M Ended 2026-06-30 | $32.03M Ended 2025-12-31 | $18.93M Ended 2025-12-31 | $119.48M Ended 2025-12-31 |
| 1 year earlier | $19.09M Ended 2025-06-30 | $25.18M Ended 2024-12-31 | $4.88M Ended 2024-12-31 | $113.69M Ended 2024-12-31 |
| 2 years earlier | $19.10M Ended 2024-06-30 | $16.03M Ended 2023-12-31 | $40.4K Ended 2023-12-31 | $130.38M Ended 2023-12-31 |
| 3 years earlier | $21.04M Ended 2023-06-30 | $8.59M Ended 2022-12-31 | n/a | $115.38M Ended 2022-12-31 |
| 4 years earlier | $15.68M Ended 2022-06-30 | $5.45M Ended 2021-12-31 | n/a | $102.60M Ended 2021-12-31 |